{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:59:45Z","timestamp":1788731985763,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-024-00626-4","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T07:02:27Z","timestamp":1707030147000},"page":"3-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obesity and Overweight: The \u201cElephant in the Room\u201d That We can No Longer Ignore: Time to SELECT Treatments"],"prefix":"10.1007","volume":"31","author":[{"given":"Armando","family":"Ferrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8380","authenticated-orcid":false,"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,4]]},"reference":[{"key":"626_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155217","volume":"133","author":"C Boutari","year":"2022","unstructured":"Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133: 155217.","journal-title":"Metabolism"},{"key":"626_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00527-y","author":"C Koliaki","year":"2023","unstructured":"Koliaki C, Dalamaga M, Liatis S. Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten? Curr Obes Rep [Internet]. 2023. https:\/\/doi.org\/10.1007\/s13679-023-00527-y.","journal-title":"Curr Obes Rep [Internet]"},{"key":"626_CR3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMc1710026","volume":"377","author":"P Bovet","year":"2017","unstructured":"Bovet P, Chiolero A, Gedeon J. Health effects of overweight and obesity in 195 countries. N Engl J Med. 2017;377:1495\u20136.","journal-title":"N Engl J Med"},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40292-021-00503-4","volume":"29","author":"M Volpe","year":"2022","unstructured":"Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G, et al. Updated recommendations on cardiovascular prevention in 2022: an executive document of the Italian Society of Cardiovascular Prevention. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2022;29:91\u2013102.","journal-title":"High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens"},{"key":"626_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1136340","author":"M Volpe","year":"2023","unstructured":"Volpe M, Gallo G. Obesity and cardiovascular disease: an executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Front Cardiovasc Med [Internet]. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1136340.","journal-title":"Front Cardiovasc Med [Internet]"},{"key":"626_CR6","unstructured":"Obesit\u00e0: da amplificatore di rischio a malattia cronica [Internet] [cited 2023 Nov 21]. https:\/\/www.siprec.it\/siprec-flipbook\/DOCUMENTO-SIPREC-2022\/."},{"key":"626_CR7","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337.","journal-title":"Eur Heart J"},{"key":"626_CR8","doi-asserted-by":"crossref","unstructured":"Kane JA, Mehmood T, Munir I, Kamran H, Kariyanna PT, Zhyvotovska A, et al. Cardiovascular risk reduction associated with pharmacological weight loss: a meta-analysis. Int J Clin Res Trials [Internet]. 2019. https:\/\/www.graphyonline.com\/archives\/IJCRT\/2019\/IJCRT-131\/index.php?page=abstract.","DOI":"10.15344\/2456-8007\/2019\/131"},{"key":"626_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med"},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989\u20131002.","journal-title":"N Engl J Med"},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344.","journal-title":"N Engl J Med"},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205\u201316.","journal-title":"N Engl J Med"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221\u201332.","journal-title":"N Engl J Med"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","volume":"134","author":"S Wharton","year":"2022","unstructured":"Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134:14\u20139.","journal-title":"Postgrad Med"},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40292-023-00588-z","volume":"30","author":"A Ferrera","year":"2023","unstructured":"Ferrera A, Battistoni A, Lanza O, Rossi C, Tocci G, Volpe M. Low perception of obesity as a pathological condition among Italian cardiologists. High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens. 2023;30:351\u20136.","journal-title":"High Blood Press Cardiovasc Prev Off J Ital Soc Hypertens"},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijcard.2023.03.054","volume":"381","author":"M Volpe","year":"2023","unstructured":"Volpe M, Borghi C, Cameli M, Cianflone D, Cittadini A, Maggioni AP, et al. How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion. Int J Cardiol. 2023;381:101\u20134.","journal-title":"Int J Cardiol"},{"key":"626_CR17","first-page":"677","volume":"24","author":"M Volpe","year":"2023","unstructured":"Volpe M, Borghi C, Cameli M, Cianflone D, Cittadini A, Maggioni AP, et al. Eight reasons why cardiologists should not overlook the problem \u201cobesity\u201d. Expert opinion for clinical practice. G Ital Cardiol. 2023;24:677\u201391.","journal-title":"G Ital Cardiol"},{"key":"626_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad875","author":"A Ferrera","year":"2024","unstructured":"Ferrera A, Battistoni A, Volpe M. Obesity who? An often-disregarded player in cardiology practice and the need for an action. Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/eurheartj\/ehad875.","journal-title":"Eur Heart J"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00626-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-024-00626-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00626-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:49:52Z","timestamp":1710355792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-024-00626-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,4]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s40292-024-00626-4","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,4]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors have no conflict of interest to disclose with the contents of the present manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"How can we reduce the burden of cardiovascular disease?\u00a0(created by Biorender).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Central figure"}}]}}